List of insiders holdings for Aclaris Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Leonard Braden Michael 10% Owner | 2024-02-08 10:47:16 | 0 9,395,934 | 9,395,934 | Form 3 |
| Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner | 2022-02-11 15:12:53 | 4,657,277 0 | 4,657,277 | Form 13G |
| VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner | 2019-02-14 15:35:52 | 1,647,214 0 | 1,647,214 | Form 13D |
| Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES AKKARAJU SRINIVAS POWELL MICHAEL 10% Owner | 2018-02-14 13:58:26 | 1,552,112 0 | 1,552,112 | Form 13D |
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-04-03 17:00:44 | 1,408,755 0 | 1,408,755 | Form 4 |
| Tullman Stephen A. Director | 2018-10-05 16:37:31 | 177,457 394,014 | 571,471 | Form 4 |
| Loerop James Chief Business Officer | 2024-02-05 19:29:48 | 492,017 0 | 492,017 | Form 4 |
| SCHIFF ANDREW N Director | 2023-06-05 16:53:44 | 24,917 434,455 | 459,372 | Form 4 |
| Powala Christopher Chief Reg & Develop Officer | 2019-02-05 18:33:25 | 151,929 130,434 | 282,363 | Form 4 |
| Monahan Joseph Chief Scientific Officer | 2024-03-05 17:04:56 | 258,633 193 | 258,826 | Form 4 |
| FMR LLC See Remark 1 | 2020-02-07 11:12:21 | 205,984 0 | 205,984 | Form 13G |
| Ruffo Frank Chief Financial Officer | 2022-03-14 16:56:19 | 201,883 0 | 201,883 | Form 4 |
| Ali-Jackson Kamil Chief Legal Officer | 2022-01-05 16:33:56 | 160,214 0 | 160,214 | Form 4 |
| Gordon David N. Chief Medical Officer | 2021-07-14 17:32:17 | 147,447 0 | 147,447 | Form 4 |
| Manion Douglas J. Pres and CEO | 2024-01-03 16:44:56 | 122,813 0 | 122,813 | Form 4 |
| Shanler Stuart Chief Scientific Officer | 2019-03-04 18:09:26 | 82,200 0 | 82,200 | Form 4 |
| Mehra Anand Director | 2023-06-05 16:45:45 | 59,114 0 | 59,114 | Form 4 |
| Cawkwell Gail Chief Medical Officer | 2023-07-05 16:23:25 | 54,593 0 | 54,593 | Form 4 |
| Molineaux Christopher P. Director | 2023-06-22 16:32:22 | 48,503 0 | 48,503 | Form 4 |
| Reasons Bryan M. Director | 2023-06-05 16:57:56 | 44,482 0 | 44,482 | Form 4 |
| Humphries William D. Director | 2023-06-05 17:12:17 | 44,482 0 | 44,482 | Form 4 |
| GOWEN MAXINE Director | 2023-06-05 17:04:19 | 32,711 0 | 32,711 | Form 4 |
| Balthaser Kevin Chief Financial Officer | 2024-03-05 17:02:09 | 29,833 0 | 29,833 | Form 4 |
| Powell Andrew Kenneth William Director | 2024-03-05 16:58:53 | 28,863 0 | 28,863 | Form 4 |
| MILANO VINCENT Director | 2023-06-05 17:08:13 | 28,273 0 | 28,273 | Form 4 |
| Fair Brett Chief Commercial Officer | 2019-02-05 18:30:05 | 22,207 0 | 22,207 | Form 4 |
| Bierly Rick Director | 2017-06-16 19:46:58 | 8000 0 | 8000 | Form 4 |
| CHA ALBERT Director | 2016-07-01 16:17:17 | 6632 0 | 6632 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 2020-02-13 12:36:57 | 0 0 | 0 | Form 13G |
| RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner | 2024-02-14 17:01:20 | 0 0 | 0 | Form 13G |